L R Espinoza Selected Research

L R Espinoza Research Topics

4	Vasculitis (Vasculitides) 10/2007 - 10/2000
2	Reactive Arthritis (Reiter Disease) 05/2010 - 02/2004
1	Infections 05/2010
1	Churg-Strauss Syndrome (Allergic Angiitis) 10/2007
1	Pancytopenia 10/2003
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2003
1	Inclusion Body Myositis 08/2001
1	Arthritis (Polyarthritis) 03/2001
1	Glomerulonephritis 03/2001
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2001
1	Proteinuria 01/2001
1	Microscopic Polyangiitis 10/2000
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 10/2000
1	Enthesopathy 06/2000
1	Uveitis 06/2000
1	Spinal Cord Diseases 01/2000
1	Optic Nerve Diseases (Optic Neuropathy) 01/2000
1	Neurologic Manifestations (Neurological Manifestations) 01/2000
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2000

2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2001 - 10/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2010
1	Anti-Infective Agents (Microbicides)IBA 05/2010
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 10/2007
1	montelukast (Singulair)FDA Link 10/2007
1	Interferon-gamma (Interferon, gamma)IBA 02/2004
1	Infliximab (Remicade)FDA Link 10/2003
1	AutoantibodiesIBA 09/2003
1	Antiphospholipid AntibodiesIBA 08/2001
1	Etanercept (Enbrel)FDA Link 08/2001
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2001
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2001
1	CreatinineIBA 01/2001
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2001
1	Rheumatoid FactorIBA 01/2001
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 06/2000
1	GlucocorticoidsIBA 01/2000
1	AnticoagulantsIBA 01/2000

1	Aftercare (After-Treatment) 01/2000